...
DVALARGE

DaVita Inc.

HealthcareMedical - Care Facilities
$156.30
$0.04(+2.46%)
52W$101.00
$157.91
FinancialsValuationvs FMS
Updated Mar 2, 12:00 AM
RSI71
RS Rating78/99
Beta0.35
Volatility37%
F-Score5/9
Mkt Cap$10.4B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

DaVita Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 78), indicating performance broadly in line with the market. Earnings contraction of 21% provides fundamental context to the price action. However, price is extended 26% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
78
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.35
vs S&P 500
LOW VOL
52W Position
97%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$123.68
50 SMA > 100 SMA$122.95
100 SMA > 150 SMA$126.84
150 SMA > 200 SMA$130.27

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$143.23+9.13%ABOVE
50 SMA$123.68+26.38%ABOVE
100 SMA$122.95+27.12%ABOVE
150 SMA$126.84+23.23%ABOVE
200 SMA$130.27+19.98%ABOVE

Price Performance

1D+2.5%
1W+3.3%
1M+47.6%
3M+30.6%
6M+14.9%
YTD+36.5%
1Y+5.7%
3Y+23.9%
52-Week Trading Range97% from low
$156.30
52W Low$101.00
52W High$157.91

Technical Indicators

RSI (14)OVERBOUGHT
71.1
305070
VCP ScoreHOT
7/10
Base depth: 36.4%

Risk Profile

Beta
0.35
52W Vol
37%
ATR
$4.70
Max DD (1Y)
-33%

Volume Analysis

Today
156
50D Avg
961.0K
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q1'25-25%
$2.00
Q2'25+3%
$2.58
Q3'25-18%
$2.04
Q4'25-21%
$2.45
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-0.10%
5 Years:+3.39%
3 Years:+5.53%
TTM:+6.46%

Compounded Profit Growth

10 Years:+21.92%
5 Years:+7.26%
3 Years:+16.68%
TTM:-15.55%

Stock Price CAGR

10 Years:+9.01%
5 Years:+8.73%
3 Years:+23.86%
1 Year:+5.69%

Return on Equity

10Y Avg:24.6%
5Y Avg:34.8%
3Y Avg:37.5%
Last Year:64.5%

Key Metrics

Market Cap$10.4B
Gross Margin27.0%
Net Margin5.5%
Piotroski F-Score5/9

More DVA Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

DVA vs FMSFMSTOICCM

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 78 meansDVA outperformed 78% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.35 means 65% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 5/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 7/10 with HOT status.

Frequently Asked Questions

Is DVA in an uptrend right now?

DVA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is DVA overbought or oversold?

DVA's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is DVA outperforming the market?

DVA has a Relative Strength (RS) Rating of 78 out of 99. DVA is performing about average compared to the market.

Where is DVA in its 52-week range?

DVA is trading at $156.30, which is 99% of its 52-week high ($157.91) and 97% above its 52-week low ($101.00).

How volatile is DVA?

DVA has a Beta of 0.35 and 52-week volatility of 37%. It's less volatile than the S&P 500 - generally more stable.